Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus
Clinical trial NCT02338609 · COMPLETED
Trial details
- NCT number
- NCT02338609
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2023-12-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.